Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Solesence (SLSN) EBT (2016 - 2025)

Solesence's EBT history spans 16 years, with the latest figure at -$154000.0 for Q4 2025.

  • For Q4 2025, EBT rose 53.47% year-over-year to -$154000.0; the TTM value through Dec 2025 reached $1.9 million, down 58.26%, while the annual FY2025 figure was $1.9 million, 58.25% down from the prior year.
  • EBT reached -$154000.0 in Q4 2025 per SLSN's latest filing, up from -$1.1 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $3.1 million in Q2 2025 to a low of -$2.1 million in Q4 2023.
  • Average EBT over 5 years is $82950.0, with a median of $45500.0 recorded in 2021.
  • Peak YoY movement for EBT: surged 884.43% in 2021, then plummeted 1969.35% in 2023.
  • A 5-year view of EBT shows it stood at -$357000.0 in 2021, then tumbled by 460.78% to -$2.0 million in 2022, then decreased by 5.99% to -$2.1 million in 2023, then skyrocketed by 84.4% to -$331000.0 in 2024, then soared by 53.47% to -$154000.0 in 2025.
  • Per Business Quant, the three most recent readings for SLSN's EBT are -$154000.0 (Q4 2025), -$1.1 million (Q3 2025), and $3.1 million (Q2 2025).